Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivors
(MedPage Today) -- The use of low-dose carvedilol did not significantly improve certain cardiac measures of heart failure risk in long-term survivors of childhood cancer exposed to anthracycline compared with placebo, the randomized phase IIb PREVENT...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Childhood Cancer | Coreg | Heart | Heart Failure | Hematology